MedPath

Screening of Obstructive Sleep Apnea Syndrome in Residents of a Unit of Long-term Care Under Mixed Food

Not Applicable
Terminated
Conditions
Obstructive Sleep Apnea Syndrome
Interventions
Device: RU sleeping®
Other: autonomy scale (ADL and AGGIR)
Other: various activity scale (IADL)
Registration Number
NCT02839499
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Obstructive sleep apnea is a condition that affects 40% to 62% of the population aged over 60 years with major consequences especially on the cardiovascular system.

This syndrome consists of a staff of the pharyngeal muscles. These muscles are also involved in swallowing phenomena and chews, or many elderly patients are subjected to a mixed diet, logically leading to atrophy of the muscles aerodigestive crossroads.

Muscle wasting ENT induced a mixed food could promote collapsibility of VAS, exposing the individual to a higher risk of apnea and hypopnea during sleep.

The objective of this study is to determine if there is a significant increase in the prevalence of obstructive sleep apnea syndrome in the elderly patients residing in long term care units, receiving a mixed food compared to residents in supply to normal texture.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Resident of a unit of long-term care
  • Recipient or affiliated with Social Security
  • Signature of consent by the patient, guardian or person of trust

and mixed food or normal texture food

Exclusion Criteria
  • OSA diagnosed and treated earlier
  • Patients with an abnormal upper airway out edentation
  • Patients unable to give informed consent and having no confidence in individual capacity to do so.
  • Patients with a gastrostomy or jejunostomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
mixed foodautonomy scale (ADL and AGGIR)experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
mixed foodvarious activity scale (IADL)experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
normal texture foodautonomy scale (ADL and AGGIR)control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
mixed foodRU sleeping®experimental group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
normal texture foodvarious activity scale (IADL)control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
normal texture foodRU sleeping®control group with RU sleeping®, autonomy scale (ADL and AGGIR) and various activity scale (IADL)
Primary Outcome Measures
NameTimeMethod
measure of the index of respiratory eventsup to 24 hours

measured with holter (RU-sleeping®)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Saint Etienne

🇫🇷

Saint Etienne, France

© Copyright 2025. All Rights Reserved by MedPath